Style | Citing Format |
---|---|
MLA | Shateri H, et al.. "Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?." Clinical Laboratory, vol. 64, no. 4, 2018, pp. 483-490. |
APA | Shateri H, Fadaei R, Najafi M, Vatannejad A, Teimouri M, Zali F, Emamgholipour S, Parvaz E, Asadnia M, Doosti M (2018). Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?. Clinical Laboratory, 64(4), 483-490. |
Chicago | Shateri H, Fadaei R, Najafi M, Vatannejad A, Teimouri M, Zali F, Emamgholipour S, Parvaz E, Asadnia M, Doosti M. "Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?." Clinical Laboratory 64, no. 4 (2018): 483-490. |
Harvard | Shateri H et al. (2018) 'Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?', Clinical Laboratory, 64(4), pp. 483-490. |
Vancouver | Shateri H, Fadaei R, Najafi M, Vatannejad A, Teimouri M, Zali F, et al.. Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?. Clinical Laboratory. 2018;64(4):483-490. |
BibTex | @article{ author = {Shateri H and Fadaei R and Najafi M and Vatannejad A and Teimouri M and Zali F and Emamgholipour S and Parvaz E and Asadnia M and Doosti M}, title = {Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?}, journal = {Clinical Laboratory}, volume = {64}, number = {4}, pages = {483-490}, year = {2018} } |
RIS | TY - JOUR AU - Shateri H AU - Fadaei R AU - Najafi M AU - Vatannejad A AU - Teimouri M AU - Zali F AU - Emamgholipour S AU - Parvaz E AU - Asadnia M AU - Doosti M TI - Circulating Levels of Il-35 and Gene Expression of Foxp3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3? JO - Clinical Laboratory VL - 64 IS - 4 SP - 483 EP - 490 PY - 2018 ER - |